CONTACT
DIAGNOSTICS
ABOUT ABBOTT
i-STAT Registration
i-STAT Login
CUSTOMER HOME
PARTNERS HOME
DISTRIBUTION HOME
EMPLOYEES HOME
REPAIR MANUAL
COMPLETE PROFILE
DASHBOARD
My Account
Indonesia

Global Point of Care

i-STAT IN CARDIOLOGY 

background image
background image
background image

reduce delays in cardiology services with patient-side testing

Delays can impact patient outcomes, so efficient testing processes are paramount to help maximize surgical outcomes. POC testing with the i-STAT System can help support the unit’s goal of expeditious care and allow surgeons to respond immediately to unstable patient conditions. In addition, the technology may streamline the blood analysis process (to potentially reduce equipment maintenance) and minimize changes in surgery schedules.

two surgeons in cardiology er two surgeons in cardiology er two surgeons in cardiology er

CVOR

KEY i-STAT CARTRIDGES

Because of the delicate nature of surgery, real-time test results are often critical, yet results from the central lab can take 60 minutes or more.1 Costly challenges, such as surgical cancellations, can add up, while the sharing of bench-top systems for blood gas analysis among a number of operating rooms can can cause delays due to the nurse having to leave the room, the system already being in use or frequent calibration requirements. The variables can potentially increase staffing requirements and impact patient care. Analysis via bench-tops (where the operating room assistant must leave the room to perform tests) can be costly, as well as potentially increase staffing requirements and impact patient care.

doctor doctor doctor

CATH LAB

KEY i‑STAT CARTRIDGES

In the Cath Lab, it’s important that both activated clotting time (ACT) and blood gas results are readily available.

The i-STAT System test menu enables Cath Labs to function with a single platform, helping to reduce costs while increasing operational efficiencies.

act testing impacts critical patient-care decisions 

in two studies, i‑STAT ACTk CARTRIDGE PERFORMED WITH BETTER PRECISION AND CROSS-DEVICE REPRODUCABILITY THAN THE HEMACHRON SIGNATURE ELITE FOR PATIENT SAMPLES, MAKING IT A PREFERRED CHOICE FOR ACT MEASUREMENT IN THE OR.2,3

background image
background image
background image

act represents the time required for a clot to form in the presence of an activator: celite or kaolin

there are two methods to measure act:

  • mechanical systems detecting blood viscosity (fibrin clot); and
  • non-mechanical systems that detect the presence of thrombin-clot through chemical assessment.

i‑STAT NON-MECHANICAL TEST

KEY ADVANTAGES
  • Earlier marker (thrombin) associated with more consistent results across duplicate ACT tests2 
  • Less susceptible to factors that affect a final physical clot3
  • Automation minimizes manual intervention and associated risks
  • Only cartridge-based ACT that can measure the entire heparin range (0-6 units/ml) with a single test. No need for high and low range ACT tests

TRADITIONAL MECHANICAL TEST

KEY DISADVANTAGES
  • Vulnerable to temperature, dilution, hematocrit, fibrinogen levels, and user technique3
  • User intervention reduces reproducibility

  • Larger sample volume in some systems limits usability for pediatric cases, impacting patient care

Interested In Learning More About How Advanced Act Testing Can Make An Impact In Your Facility?

PRODUCT CATALOG
background image
background image
background image
related studies
changing changing changing
changing the face of cardiac surgery
read study
changing changing changing
Poc testing in the cvor
read study
man shoveling man shoveling man shoveling
The seasonal rise in cardiac events
read study

references

  1. M. Kankaanpää, et al., Use of point-of-care testing and early assessment model reduces length of stay for ambulatory patients in an emergency department. Scand J Trauma Resusc Emerg Med. 2016 Oct 18;24(1): 125.doi: 10.1186/s13049-016-0319-z.
  2. Lilah M.Evans, Susanne Gallo, Joseph J. Leo, Barbara, M.Goldsmith, Activated Clotting Time (ACT): Comparison of the Hemochron Signature Elite and the Abbott i-STAT.
  3. Kemna EW, Kuipers C, Oude Luttikhuis-Spanjer AM, et al. A two-site comparison of two point-of-care activated clotting time systems. Clin Chem Lab Med. 2017;55(1):e13-e16.

a leader in rapid point-of-care diagnostics.

PRODUCT CATALOG
SOLUTIONS
CUSTOMER STORIES
VIEWPOINTS
CONTACT US
PRODUCT DOCUMENT SEARCH
PRODUCT DEMOS
INTEREST-BASED ADS

©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement

Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.

Abbott - A Leader in Rapid Point-of-Care Diagnostics.